Recombinant reteplase (Beijing Jiangzhong Pharmaceutical)
重组瑞替普酶（北京江中药物研究所）
Report date: 2023/07/13 10:39:01
Base Information
Drug NameRecombinant reteplase (Beijing Jiangzhong Pharmaceutical)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesJiangsu Jiangzhong Group Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBeijing Jiangzhong Pharmaceutical Research Institute
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A